Fucoxanthin reportedly can inhibit the malignant proliferation of non-small cell lung cancer by inhibiting phosphorylation of the PI3K/AKT pathway, thereby suppressing its signaling activity [37]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.